SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-016104
Filing Date
2019-06-07
Accepted
2019-06-07 20:00:50
Documents
2
Period of Report
2019-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1623
2 EX-24 DOCUMENT attachment1.htm EX-24 5306
  Complete submission text file 0000899243-19-016104.txt   8294
Mailing Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address DICERNA PHARMACEUTICALS, INC. 87 CAMBRIDGEPARK DRIVE CAMBRIDGE MA 02140
Business Address
Ciappenelli Robert D. (Reporting) CIK: 0001778786 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36281 | Film No.: 19887355